Systemic Corticosteroids and the Risk of Venous Thromboembolism in Patients with Severe COPD: A Nationwide Study of 30,473 Outpatients

Due to frequent exacerbations, many patients with chronic obstructive pulmonary disease (COPD) are exposed to oral corticosteroids (OCS), which may be thrombogenic. We evaluated the risk of hospitalisation with venous thromboembolism (VTE) and death in patients with acute exacerbation of COPD (AECOPD) treated with long and short OCS regimens. In this nationwide cohort study of 30,473 COPD outpatients treated for AECOPD, we compared the risk of VTE hospitalisation and all-cause mortality within 6 months in OCS dose of >250 mg vs. ≤250 mg. A multivariable Cox proportional hazard regression was used to estimate the risk. The incidence of VTE hospitalisations was 0.23%. A long OCS treatment course was associated with an increased risk of VTE compared to a short course (hazard ratio (HR) 1.69, [95% confidence interval (CI) 1.05 to 2.72], p < 0.031). A higher risk of all-cause mortality was seen in the group of COPD patients treated with a long OCS course (HR 1.71, [95% CI 1.63 to 1.79], p < 0.0001). The risk of reported VTE hospitalisation was higher among AECOPD patients treated with long courses of OCS, but the absolute risk was low, suggesting under-reporting of the condition.

[1]  C. Tromeur,et al.  Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms. , 2021, JAMA.

[2]  T. Biering-Sørensen,et al.  Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary disease , 2020, Diabetes, obesity & metabolism.

[3]  W. Mack,et al.  Venous Thromboembolism After Degenerative Spine Surgery: A Nationwide Readmissions Database Analysis. , 2019, World neurosurgery.

[4]  N. Seersholm,et al.  COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 months , 2019, BMJ Open Respiratory Research.

[5]  C. Sabapathy,et al.  Risk factors for post-discharge venous thromboembolism in patients undergoing colorectal resection: a NSQIP analysis , 2018, Techniques in Coloproctology.

[6]  J. Pines,et al.  Pulmonary Embolism Among Patients With Acute Exacerbation Of Chronic Obstructive Pulmonary Disease: Implications For Emergency Medicine. , 2018, The Journal of emergency medicine.

[7]  M. Rogers,et al.  Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study , 2017, British Medical Journal.

[8]  Q. de Mast,et al.  Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta‐analysis , 2017, Chest.

[9]  J. Sundquist,et al.  Risk of pulmonary embolism and deep venous thrombosis in patients with asthma: a nationwide case−control study from Sweden , 2017, European Respiratory Journal.

[10]  P. Lange,et al.  Danish Register of chronic obstructive pulmonary disease , 2016, Clinical epidemiology.

[11]  T. van der Poll,et al.  UvA-DARE ( Digital Academic Repository ) Asthma and coagulation : A clinical and pathophysiological evaluation , 2016 .

[12]  E. Connolly,et al.  Association of Steroid Use with Deep Venous Thrombosis and Pulmonary Embolism in Neurosurgical Patients: A National Database Analysis. , 2016, World neurosurgery.

[13]  Sigrun Alba Johannesdottir Schmidt,et al.  The Danish National Patient Registry: a review of content, data quality, and research potential , 2015, Clinical epidemiology.

[14]  Rami S. Kantar,et al.  Venous thromboembolism and preoperative steroid use: analysis of the NSQIP database to evaluate risk in surgical patients. , 2015, European journal of internal medicine.

[15]  V. Kim,et al.  Risk Factors for Venous Thromboembolism in Chronic Obstructive Pulmonary Disease. , 2014, Chronic obstructive pulmonary diseases.

[16]  J. Torres-Macho,et al.  Clinical features of patients inappropriately undiagnosed of pulmonary embolism. , 2013, The American journal of emergency medicine.

[17]  N. Bateman Use of glucocorticoids and risk of venous thromboembolism: a nationwide population‐based case–control study , 2013 .

[18]  M. Briel,et al.  Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. , 2013, JAMA.

[19]  E. Horváth-Puhó,et al.  Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. , 2013, JAMA internal medicine.

[20]  P. Souverein,et al.  Use of oral glucocorticoids and the risk of pulmonary embolism: a population-based case-control study. , 2013, Chest.

[21]  A. Zwinderman,et al.  Risk of deep vein thrombosis and pulmonary embolism in asthma , 2012, European Respiratory Journal.

[22]  Henrik Toft Sørensen,et al.  Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions , 2012, Clinical epidemiology.

[23]  C. Bédard,et al.  Effect of prednisone administration on coagulation variables in healthy Beagle dogs. , 2011, Veterinary clinical pathology.

[24]  L. Bertoletti,et al.  Clinical presentation and outcome of venous thromboembolism in COPD , 2011, European Respiratory Journal.

[25]  H. Gunen,et al.  Venous thromboemboli and exacerbations of COPD , 2009, European Respiratory Journal.

[26]  O. Gajic,et al.  A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation. , 2009, Chest.

[27]  D. Sin,et al.  Prevalence of pulmonary embolism in acute exacerbations of COPD: a systematic review and metaanalysis. , 2009, Chest.

[28]  C. Huerta,et al.  Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. , 2007, Archives of internal medicine.

[29]  D. Jiménez,et al.  Pulmonary embolism in patients with chronic obstructive pulmonary disease or congestive heart failure. , 2006, The American journal of medicine.

[30]  C. Marquette,et al.  Pulmonary Embolism in Patients with Unexplained Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence and Risk Factors , 2006, Annals of Internal Medicine.

[31]  R. Pauwels,et al.  Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary Updated 2003 , 2004, COPD.

[32]  J. T. Owings,et al.  Biochemical basis for the hypercoagulable state seen in Cushing syndrome; discussion 1006-7. , 2001, Archives of surgery.

[33]  B. Grant,et al.  Clinical suspicion of fatal pulmonary embolism. , 2001, Chest.